ITGI, Vascular Solutions Aim for Q1 2017 Launch of Dx Stent

A A
ITGI Medical and Vascular Solutions plan to begin enrolling patients in a humanitarian device exemption trial of ITGI’s Aneugraft Dx coronary stent during the first quarter of next year.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00